Analyst: Singulair might draw at-risk copy - FiercePharma
Analyst: Singulair might draw at-risk copy FiercePharma, DC - Teva ambushed Wyeth with a generic version of the acid-reflux remedy Protonix right in the middle of the two companies' patent fight over the drug. ... |
Original post: Analyst: Singulair might draw at-risk copy - FiercePharma by ©2008 Google at acid reflux remedies - Google News
Blog tag: Acid reflux remedies
Technorati tag: Acid reflux remedies